✦ LIBER ✦
A cost-effectiveness analysis of sunitinib in patients with metastatic renal cell carcinoma intolerant to or experiencing disease progression on immunotherapy: perspective of the Spanish National Health System
✍ Scribed by L. Paz-Ares; J. G. Del Muro; E. Grande; S. Díaz
- Book ID
- 108849333
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 170 KB
- Volume
- 35
- Category
- Article
- ISSN
- 0269-4727
No coin nor oath required. For personal study only.